SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 129 filers reported holding SCICLONE PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $139,000 | -2.1% | 10,678 | -17.3% | 0.01% | 0.0% |
Q1 2016 | $142,000 | -43.4% | 12,918 | -52.7% | 0.01% | -45.5% |
Q4 2015 | $251,000 | +19.0% | 27,314 | -10.2% | 0.01% | +22.2% |
Q3 2015 | $211,000 | -31.7% | 30,416 | -3.3% | 0.01% | -18.2% |
Q2 2015 | $309,000 | -13.0% | 31,463 | -21.5% | 0.01% | -8.3% |
Q1 2015 | $355,000 | +42.6% | 40,055 | +41.1% | 0.01% | +50.0% |
Q4 2014 | $249,000 | -12.6% | 28,389 | -31.3% | 0.01% | -11.1% |
Q3 2014 | $285,000 | +18.3% | 41,299 | -9.8% | 0.01% | +28.6% |
Q2 2014 | $241,000 | -15.4% | 45,772 | -27.0% | 0.01% | -12.5% |
Q1 2014 | $285,000 | +203.2% | 62,713 | +234.6% | 0.01% | +166.7% |
Q4 2013 | $94,000 | -1.1% | 18,742 | 0.0% | 0.00% | +50.0% |
Q3 2013 | $95,000 | +30.1% | 18,742 | +28.1% | 0.00% | 0.0% |
Q2 2013 | $73,000 | – | 14,627 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athos Capital Ltd | 410,389 | $4,596,000 | 3.46% |
GLG Partners LP | 2,586,437 | $28,968,000 | 1.54% |
Nine Chapters Capital Management LLC | 32,300 | $362,000 | 0.80% |
FNY Partners Fund LP | 335,900 | $3,762,000 | 0.64% |
MENTA CAPITAL LLC | 373,523 | $4,183,000 | 0.61% |
Yakira Capital Management, Inc. | 85,500 | $958,000 | 0.32% |
Sapphire Star Partners LP | 18,724 | $209,000 | 0.27% |
GAM Holding AG | 541,025 | $6,059,000 | 0.26% |
Bowling Portfolio Management LLC | 127,873 | $1,432,000 | 0.22% |
Kassirer Asset Management Corp | 15,000 | $168,000 | 0.16% |